A detailed history of Catalyst Funds Management Pty LTD transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 11,200 shares of CDMO stock, worth $137,312. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,200
Holding current value
$137,312
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.7 - $12.45 $75,040 - $139,440
11,200 New
11,200 $127 Million
Q1 2024

Dec 04, 2024

BUY
$5.86 - $8.79 $242,604 - $363,905
41,400 Added 369.64%
52,600 $352 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $762M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.